HOME >> MEDICINE >> NEWS
Researchers discover new way to stimulate brain to release antioxidants

A joint research effort between researchers at the Burnham Institute for Medical Research in La Jolla, CA, and a team from Japan (Iwate University, Osaka City University, Gifu University, Iwate Medical University) has discovered a novel way to treat stroke and neurodegenerative disorders. This approach works by inducing nerve cells in the brain and the spine to release natural antioxidants that protect nerve cells from stress and free radicals that lead to neurodegenerative diseases. Until this discovery, researchers were unable to induce release of these specific antioxidants directly in nerve cells, at the site where damage and degeneration occurs.

In stroke and various neurodegenerative disorders, such as Alzheimer's disease and Lou Gehrig's disease, glutamate, an amino acid found in high quantities in the brain, is thought to accumulate. At normal concentrations, glutamate acts as a neurotransmitter that nerves use to communicate. However, at excessive levels glutamate is toxic, resulting in over stimulation of nerve cells, known as excitotoxicity, and causing excessive stress on the nerve cells eventually ending in cell death. Studies described in this report suggest that NEPPs (short for NEurite outgrowth-Promoting Prostaglandins), compounds that accumulate in nerve cells, prevent nerve damage by activating the Keap1/Nrf2 pathway that regulates the production of antioxidants which relieve cells of damaging free radicals that result from excitotoxicity.

"This is the first reported evidence that this protective response can be activated directly in nerve cells to release antioxidants and counter oxidative stress," said Stuart Lipton, M.D., Ph.D., Director of the Del E. Webb Center for Neurosciences and Aging at the Burnham Institute and senior author of the study. "These findings provide support for further investigation of NEPP drugs to potentially treat ischemic stroke, multiple sclerosis, Alzheimer's disease, Lou Gehrig's disease and other
'"/>

Contact: Nancy Beddingfield
nbeddingfield@burnham.org
858-646-3146
Burnham Institute
9-Jan-2006


Page: 1 2

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
5. Researchers call for investigation into links between khat use and psychiatric disorders
6. Researchers use MRI to predict recovery after spinal cord injury
7. Researchers find deadly prescription drug effects 6 years before FDA
8. Researchers investigate impact of lifestyle on GI health
9. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
10. Researchers discover how antibiotic inhibits bacterial growth
11. Researchers urge caution in using ESAs for cancer-related anemia

Post Your Comments:
(Date:7/23/2014)... Recently, Agebc.com has launched its new ... is announcing a promotion of wedding dresses. According to ... at the end of this month. , The beautiful ... like A-line, mermaid, ball-gown, empire, and more. Agebc.com is ... special-occasion dresses for women, and the company is devoted ...
(Date:7/23/2014)... Adipic acid is an intermediate chemical ... plastic, often referred to as engineering thermoplastics. These ... the monomers employed. Due to the high production ... increasing number of developing countries, the Asia-Pacific region ... by Europe and North America. Adipic acid in ...
(Date:7/23/2014)... The European Vitamins Market report explains and divides ... of revenue. The market in Europe is estimated to ... million by 2018, at a CAGR of 6.8% from ... the European Vitamins Market report, to get an idea ... glimpse of the segmentation in the European market, and ...
(Date:7/23/2014)... Texas (PRWEB) July 23, 2014 ... 2020?, provides key market data on the North ... value, in millions of US dollars, and volume ... dollars), within market categories Cardiac Valve Repairs and ... shares and distribution shares data for each of ...
(Date:7/23/2014)... who suffered repeated blows to the head during their ... clumps suggest the athletes had a disease called chronic ... that might be able to detect CTE in its ... & Engineering News (C&EN) , the weekly news magazine ... Lauren Wolf, a senior editor at C&EN, explains that ...
Breaking Medicine News(10 mins):Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5
(Date:7/23/2014)... YORK , July 23, 2014  Dompe, a leader ... rare diseases, announces that rhNGF (Recombinant Human Nerve Growth Factor) ... Food and Drug Administration (FDA). The candidate ... as an orphan drug for the treatment of neurotrophic keratitis, ... 5,000 people 1 and is currently without a cure. ...
(Date:7/23/2014)... July 23, 2014  ArmaGen, a privately held ... treat severe neurological disorders, announced today that it ... agreement with Shire plc to develop AGT-182, an ... of both the central nervous system (CNS) and ... as MPS II, Hunter syndrome is a rare, ...
(Date:7/23/2014)... July 23, 2014 ... Arbeiten für Sadara Chemical Company (Sadara) erhalten ... System innerhalb des integrierten Chemiekomplexes von Sadara ... additional scope im Wert von mehreren Millionen ... Vertrags dar, dessen Wert sich ebenfalls auf ...
Breaking Medicine Technology:Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4
Cached News: